Anzeige
Mehr »
Donnerstag, 18.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
402 Leser
Artikel bewerten:
(1)

Canafarma Hemp Products Corp. Announces RTO Closing and CSE Listing

TORONTO, ON / ACCESSWIRE / March 9, 2020 / CanaFarma Hemp Products Corp. (formerly KYC Technology Inc.) (the "Corporation" or "CanaFarma Hemp") is pleased to announce that it has completed the previously announced merger of CanaFarma Corp. ("CanaFarma") and a wholly-owned subsidiary of the Corporation ("Subco") whereby the Corporation acquired all of the outstanding securities of CanaFarma pursuant to a merger completed under the laws of the State of Delaware (the "Transaction"). Pursuant to the Transaction, Subco merged with and into CanaFarma, and CanaFarma became a wholly-owned subsidiary of the Corporation, as described in the non-offering prospectus of the Corporation dated February 27, 2020, which also provides a description of CanaFarma (to be found under the Corporation's profile at www.sedar.com).

In connection with the Transaction, the Corporation (whose previous name was KYC Technology Inc.) changed its name to CanaFarma Hemp Products Corp., completed a share split on the basis of 17.7574 new common shares (each, a "Common Share") for each one (1) previously held share of KYC (resulting in former KYC holders now holding an aggregate of 44,393,518 Common Shares) and amended its share capital to create a class of proportionate voting shares (the "Proportionate Voting Shares"). Concurrently, the Corporation issued an aggregate of 142,922,000 Common Shares and 57,000 Proportionate Voting Shares as consideration to the former holders of common shares in the capital of CanaFarma. As a result, there are now a total of 187,315, 518 Common Shares and 57,000 Proportionate Voting Shares issued and outstanding.

In addition, effective at the open of market on Tuesday, March 17th, 2020, the Common Shares of the Corporation will commence trading on the Canadian Securities Exchange (CSE) under the symbol "CNFA".

David Lonsdale, CEO of CanaFarma commented: "We are thrilled to commence our listing on the CSE, the world's preeminent public exchange for innovative CBD and hemp-based product companies. CanaFarma has demonstrated positive early success in its product sales and we look forward to further expanding and pursuing our various growth opportunities, which this Transaction and CSE share listing will help to facilitate."

About CanaFarma Hemp Products Corp.

CanaFarma Hemp is a full-service company operating in the hemp industry offering a full range of hemp-related products and services. These products and services include growing top-quality hemp, providing

hemp-processing services, and offering hemp-based products to consumers utilizing a direct-to-consumer marketing approach.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to future developments and the business and operations of the Corporation after the CSE listing. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. Readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

FOR FURTHER INFORMATION, PLEASE CONTACT:

David Lonsdale
Chief Executive Officer,
Phone: (214) 704-7942
Email: david@canafarmacorp.com

SOURCE: Canafarma Hemp Products Corp.



View source version on accesswire.com:
https://www.accesswire.com/579596/Canafarma-Hemp-Products-Corp-Announces-RTO-Closing-and-CSE-Listing

© 2020 ACCESS Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.